Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2024	Jun. 30, 2024
Current assets
Cash and cash equivalents	$ 290	$ 202
Receivables, net	603	695
Inventories, net	592	637
Prepaid expenses and other current assets	147	88
Total current assets	1,632	1,622
Property, plant and equipment, net of accumulated depreciation and amortization of $2,831 and $2,821, respectively	1,242	1,315
Operating lease right-of-use assets	362	360
Goodwill	1,219	1,228
Trademarks, net	501	538
Other intangible assets, net	73	143
Other assets	548	545
Total assets	5,577	5,751
Current liabilities
Notes and loans payable	189	4
Current operating lease liabilities	81	84
Accounts payable and accrued liabilities	1,460	1,486
Total current liabilities	1,730	1,574
Long-term debt	2,483	2,481
Long-term operating lease liabilities	339	334
Other liabilities	882	848
Deferred income taxes	22	22
Total liabilities	5,456	5,259
Commitments and contingencies
Stockholders’ equity
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of December 31, 2024 and June 30, 2024; and 123,150,847 and 124,201,807 shares outstanding as of December 31, 2024 and June 30, 2024, respectively	131	131
Additional paid-in capital	1,287	1,288
Retained earnings	68	250
Treasury stock, at cost: 7,590,614 and 6,539,654 shares as of December 31, 2024 and June 30, 2024, respectively	(1,346)	(1,186)
Accumulated other comprehensive net (loss) income	(181)	(155)
Total Clorox stockholders’ (deficit) equity	(41)	328
Noncontrolling interests	162	164
Total stockholders’ equity	121	492
Total liabilities and stockholders’ equity	$ 5,577	$ 5,751